Drugs / NAI
last change Nov 2017 re-read 2 minutes ago

NAI

Developed for
urinary bladder cancer · urothelial carcinoma
Investigated by
AstraZeneca · Hoosier Cancer Research Network · ImmunityBio, Inc. · Noah Hahn, M.D.

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT03317158 Nov 2017 → Dec 2028 expected urinary bladder cancer, urothelial carcinoma Noah Hahn, M.D. Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NAI ClinicalTrials.gov intervention name — accepted as the source's own label NCT03317158